@article{17151d0ea00d4a0ca19dde9a04689ce1,
title = "Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation – First case series from a single institution",
keywords = "AML, Acute myeloid leukemia, BCR-ABL1, CML, Chronic myeloid leukemia, NPM1 mutation",
author = "Young, {Paul E.} and Rashmi Kanagal-Shamanna and Shimin Hu and Guilin Tang and Beenu Thakral and Naval Daver and Issa, {Ghayas C.} and Medeiros, {L. Jeffrey} and Sergej Konoplev",
note = "Funding Information: Naval Daver has received research funding from Daiichi-Sankyo, Bristol-Myers Squibb, Pfizer, Gilead, Sevier, Genentech, Astellas, Daiichi-Sankyo, Abbvie, Hanmi, Trovagene, FATE therapeutics, Amgen, Novimmune, Glycomimetics, Trillium, and ImmunoGen and has served in a consulting or advisory role for Daiichi-Sankyo, Bristol-Myers Squibb, Arog, Pfizer, Novartis, Jazz, Celgene, AbbVie, Astellas, Genentech, Immunogen, Servier, Syndax, Trillium, Gilead, Amgen, Shattuck labs, and Agios. Ghayas C. Issa has received research funding from Celgene, Kura Oncology, Syndax and Novartis, and received consultancy fees from Novartis and Kura Oncology. Other authors declare no conflict of interest. ",
year = "2021",
month = dec,
doi = "10.1016/j.leukres.2021.106685",
language = "English (US)",
volume = "111",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
}